{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T01:03:16Z","timestamp":1785286996149,"version":"3.55.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,30]],"date-time":"2019-04-30T00:00:00Z","timestamp":1556582400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,4,30]],"date-time":"2019-04-30T00:00:00Z","timestamp":1556582400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008272","name":"Novartis Pharmaceuticals Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13023-019-1072-y","type":"journal-article","created":{"date-parts":[[2019,4,30]],"date-time":"2019-04-30T12:04:24Z","timestamp":1556625864000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["A step-wise approach for establishing a multidisciplinary team for the management of tuberous sclerosis complex: a Delphi consensus report"],"prefix":"10.1186","volume":"14","author":[{"given":"St\u00e9phane","family":"Auvin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Bissler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Cottin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayataka","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcnther F. L.","family":"Hofbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna C.","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergiusz","family":"J\u00f3\u017awiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larissa","family":"Kerecuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Christopher","family":"Kingswood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romina","family":"Moavero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roser","family":"Torra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente","family":"Villanueva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,30]]},"reference":[{"key":"1072_CR1","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/j.1749-6632.1991.tb37754.x","volume":"615","author":"JP Osborne","year":"1991","unstructured":"Osborne JP, Fryer A, Webb D. Epidemiology of tuberous sclerosis. Ann N Y Acad Sci. 1991;615:125\u20137.","journal-title":"Ann N Y Acad Sci"},{"issue":"9639","key":"1072_CR2","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/S0140-6736(08)61279-9","volume":"372","author":"P Curatolo","year":"2008","unstructured":"Curatolo P, Bombardieri R, Jozwiak S. Tuberous sclerosis. Lancet. 2008;372(9639):657\u201368.","journal-title":"Lancet."},{"issue":"5","key":"1072_CR3","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1055\/s-0030-1269906","volume":"41","author":"DN Franz","year":"2010","unstructured":"Franz DN, Bissler JJ, McCormack FX. Tuberous sclerosis complex: neurological, renal and pulmonary manifestations. Neuropediatrics. 2010;41(5):199\u2013208.","journal-title":"Neuropediatrics."},{"key":"1072_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/TACG.S90262","volume":"10","author":"C Caban","year":"2017","unstructured":"Caban C, Khan N, Hasbani DM, Crino PB. Genetics of tuberous sclerosis complex: implications for clinical practice. Appl Clin Genet. 2017;10:1\u20138.","journal-title":"Appl Clin Genet"},{"issue":"13","key":"1072_CR5","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1056\/NEJMra055323","volume":"355","author":"PB Crino","year":"2006","unstructured":"Crino PB, Nathanson KL, Henske EP. The tuberous sclerosis complex. N Engl J Med. 2006;355(13):1345\u201356.","journal-title":"N Engl J Med"},{"issue":"Suppl 3","key":"1072_CR6","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/epi.12722","volume":"55","author":"EA Thiele","year":"2014","unstructured":"Thiele EA, Granata T, Matricardi S, Chugani HT. Transition into adulthood: tuberous sclerosis complex, Sturge-weber syndrome, and Rasmussen encephalitis. Epilepsia. 2014;55(Suppl 3):29\u201333.","journal-title":"Epilepsia."},{"issue":"9","key":"1072_CR7","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1136\/archdischild-2016-312001","volume":"102","author":"MA Cardis","year":"2017","unstructured":"Cardis MA, DeKlotz CMC. Cutaneous manifestations of tuberous sclerosis complex and the paediatrician's role. Arch Dis Child. 2017;102(9):858\u201363.","journal-title":"Arch Dis Child"},{"issue":"1","key":"1072_CR8","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13023-016-0553-5","volume":"12","author":"JC Kingswood","year":"2017","unstructured":"Kingswood JC, d'Augeres GB, Belousova E, Ferreira JC, Carter T, Castellana R, et al. TuberOus SClerosis registry to increase disease awareness (TOSCA) - baseline data on 2093 patients. Orphanet J Rare Dis. 2017;12(1):2.","journal-title":"Orphanet J Rare Dis."},{"issue":"1","key":"1072_CR9","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.pediatrneurol.2014.10.004","volume":"52","author":"PJ de Vries","year":"2015","unstructured":"de Vries PJ, Whittemore VH, Leclezio L, Byars AW, Dunn D, Ess KC, et al. Tuberous sclerosis associated neuropsychiatric disorders (TAND) and the TAND checklist. Pediatr Neurol. 2015;52(1):25\u201335.","journal-title":"Pediatr Neurol"},{"issue":"2","key":"1072_CR10","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/YCO.0000000000000136","volume":"28","author":"L Leclezio","year":"2015","unstructured":"Leclezio L, de Vries PJ. Advances in the treatment of tuberous sclerosis complex. Curr Opin Psychiatry. 2015;28(2):113\u201320.","journal-title":"Curr Opin Psychiatry"},{"issue":"1","key":"1072_CR11","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.pediatrneurol.2014.10.006","volume":"52","author":"L Leclezio","year":"2015","unstructured":"Leclezio L, Jansen A, Whittemore VH, de Vries PJ. Pilot validation of the tuberous sclerosis-associated neuropsychiatric disorders (TAND) checklist. Pediatr Neurol. 2015;52(1):16\u201324.","journal-title":"Pediatr Neurol"},{"issue":"3","key":"1072_CR12","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/ajmg.c.31637","volume":"178","author":"PJ de Vries","year":"2018","unstructured":"de Vries PJ, Wilde L, de Vries MC, Moavero R, Pearson DA, Curatolo P. A clinical update on tuberous sclerosis complex-associated neuropsychiatric disorders (TAND). Am J Med Genet C Semin Med Genet. 2018;178(3):309\u201320.","journal-title":"Am J Med Genet C Semin Med Genet."},{"key":"1072_CR13","unstructured":"Afinitor\/Afinitor Disperz [prescribing information]. East Hanover, NJ: Novartis Pharmaceuticals Corporation; April 2018."},{"key":"1072_CR14","unstructured":"Votubia [summary of product characteristics]. Nuremberg, Germany: Novartis Pharma GmbH; 2018."},{"issue":"6","key":"1072_CR15","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1002\/ajmg.a.37644","volume":"170","author":"A Peron","year":"2016","unstructured":"Peron A, Vignoli A, La Briola F, Volpi A, Montanari E, Morenghi E, et al. Do patients with tuberous sclerosis complex have an increased risk for malignancies? Am J Med Genet A. 2016;170(6):1538\u201344.","journal-title":"Am J Med Genet A"},{"issue":"2","key":"1072_CR16","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s10689-017-0029-3","volume":"17","author":"P Mortaji","year":"2018","unstructured":"Mortaji P, Morris KT, Samedi V, Eberhardt S, Ryan S. Pancreatic neuroendocrine tumor in a patient with a TSC1 variant: case report and review of the literature. Familial Cancer. 2018;17(2):275\u201380.","journal-title":"Familial Cancer"},{"issue":"6","key":"1072_CR17","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.bpg.2012.12.003","volume":"26","author":"T Ito","year":"2012","unstructured":"Ito T, Igarashi H, Jensen RT. Pancreatic neuroendocrine tumors: clinical features, diagnosis and medical treatment: advances. Best Pract Res Clin Gastroenterol. 2012;26(6):737\u201353.","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"1072_CR18","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.pediatrneurol.2013.08.001","volume":"49","author":"H Northrup","year":"2013","unstructured":"Northrup H, Krueger DA. Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 international tuberous sclerosis complex consensus conference. Pediatr Neurol. 2013;49:243\u201354.","journal-title":"Pediatr Neurol"},{"key":"1072_CR19","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.pediatrneurol.2013.08.002","volume":"49","author":"DA Krueger","year":"2013","unstructured":"Krueger DA, Northrup H. Tuberous sclerosis complex surveillance and management: recommendations of the 2012 international tuberous sclerosis complex consensus conference. Pediatr Neurol. 2013;49:255\u201365.","journal-title":"Pediatr Neurol"},{"key":"1072_CR20","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.yebeh.2016.11.010","volume":"69","author":"R Nabbout","year":"2017","unstructured":"Nabbout R, Andrade DM, Bahi-Buisson N, Cross H, Desquerre I, Dulac O, et al. Outcome of childhood-onset epilepsy from adolescence to adulthood: transition issues. Epilepsy Behav. 2017;69:161\u20139.","journal-title":"Epilepsy Behav"},{"issue":"7","key":"1072_CR21","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/S1474-4422(15)00069-1","volume":"14","author":"P Curatolo","year":"2015","unstructured":"Curatolo P, Moavero R, de Vries PJ. Neurological and neuropsychiatric aspects of tuberous sclerosis complex. Lancet Neurol. 2015;14(7):733\u201345.","journal-title":"Lancet Neurol"},{"issue":"8","key":"1072_CR22","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.1245\/s10434-016-5178-3","volume":"23","author":"YL Basta","year":"2016","unstructured":"Basta YL, Baur OL, van Dieren S, Klinkenbijl JH, Fockens P, Tytgat KM. Is there a benefit of multidisciplinary cancer team meetings for patients with gastrointestinal malignancies? Ann Surg Oncol. 2016;23(8):2430\u20137.","journal-title":"Ann Surg Oncol"},{"key":"1072_CR23","first-page":"79","volume":"5","author":"C Taylor","year":"2013","unstructured":"Taylor C, Shewbridge A, Harris J, Green JS. Benefits of multidisciplinary teamwork in the management of breast cancer. Breast Cancer. 2013;5:79\u201385.","journal-title":"Breast Cancer"},{"key":"1072_CR24","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.oraloncology.2016.06.002","volume":"59","author":"L Licitra","year":"2016","unstructured":"Licitra L, Keilholz U, Tahara M, Lin JC, Chomette P, Ceruse P, et al. Evaluation of the benefit and use of multidisciplinary teams in the treatment of head and neck cancer. Oral Oncol. 2016;59:73\u20139.","journal-title":"Oral Oncol"},{"issue":"6","key":"1072_CR25","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1016\/j.chest.2018.03.026","volume":"153","author":"LJ De Sadeleer","year":"2018","unstructured":"De Sadeleer LJ, Meert C, Yserbyt J, Slabbynck H, Verschakelen JA, Verbeken EK, et al. Diagnostic ability of a dynamic multidisciplinary discussion in interstitial lung diseases: a retrospective observational study of 938 cases. Chest. 2018;153(6):1416\u201323.","journal-title":"Chest."},{"issue":"2","key":"1072_CR26","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/S2213-2600(17)30433-2","volume":"6","author":"DA Lynch","year":"2018","unstructured":"Lynch DA, Sverzellati N, Travis WD, Brown KK, Colby TV, Galvin JR, et al. Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner society white paper. Lancet Respir Med. 2018;6(2):138\u201353.","journal-title":"Lancet Respir Med"},{"key":"1072_CR27","doi-asserted-by":"publisher","first-page":"c951","DOI":"10.1136\/bmj.c951","volume":"340","author":"C Taylor","year":"2010","unstructured":"Taylor C, Munro AJ, Glynne-Jones R, Griffith C, Trevatt P, Richards M, et al. Multidisciplinary team working in cancer: what is the evidence? BMJ. 2010;340:c951.","journal-title":"BMJ."},{"key":"1072_CR28","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.yebeh.2018.03.012","volume":"83","author":"P Both","year":"2018","unstructured":"Both P, Ten Holt L, Mous S, Patist J, Rietman A, Dieleman G, et al. Tuberous sclerosis complex: concerns and needs of patients and parents from the transitional period to adulthood. Epilepsy Behav. 2018;83:13\u201321.","journal-title":"Epilepsy Behav"},{"issue":"3","key":"1072_CR29","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/ajmg.c.31653","volume":"178","author":"A Peron","year":"2018","unstructured":"Peron A, Canevini MP, Ghelma F, Di Marco F, Vignoli A. Healthcare transition from childhood to adulthood in tuberous sclerosis complex. Am J Med Genet C Semin Med Genet. 2018;178(3):355\u201364.","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"12","key":"1072_CR30","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1177\/0883073815575364","volume":"30","author":"AM Rentz","year":"2015","unstructured":"Rentz AM, Skalicky AM, Pashos CL, Liu Z, Magestro M, Pelletier CL, et al. Caring for children with tuberous sclerosis complex: what is the physical and mental health impact on caregivers? J Child Neurol. 2015;30(12):1574\u201381.","journal-title":"J Child Neurol"},{"issue":"1","key":"1072_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-35168-y","volume":"8","author":"A Fujimoto","year":"2018","unstructured":"Fujimoto A, Okanishi T, Imai S, Ogai M, Fukunaga A, Nakamura H, et al. Establishment of a regional interdisciplinary medical system for managing patients with tuberous sclerosis complex (TSC). Sci Rep. 2018;8(1):16747.","journal-title":"Sci Rep"},{"issue":"10","key":"1072_CR32","first-page":"8","volume":"12","author":"C-C Hsu","year":"2007","unstructured":"Hsu C-C, Sandford BA. The Delphi technique: making sense of consensus. Pract Assess Res Eval. 2007;12(10):8.","journal-title":"Pract Assess Res Eval"},{"issue":"10","key":"1072_CR33","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1007\/s00467-014-3027-9","volume":"30","author":"L De Waele","year":"2015","unstructured":"De Waele L, Lagae L, Mekahli D. Tuberous sclerosis complex: the past and the future. Pediatr Nephrol. 2015;30(10):1771\u201380.","journal-title":"Pediatr Nephrol"},{"issue":"8","key":"1072_CR34","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1185\/03007995.2011.586687","volume":"27","author":"L Hallett","year":"2011","unstructured":"Hallett L, Foster T, Liu Z, Blieden M, Valentim J. Burden of disease and unmet needs in tuberous sclerosis complex with neurological manifestations: systematic review. Curr Med Res Opin. 2011;27(8):1571\u201383.","journal-title":"Curr Med Res Opin"},{"issue":"1","key":"1072_CR35","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13023-018-0764-z","volume":"13","author":"M Slowinska","year":"2018","unstructured":"Slowinska M, Jozwiak S, Peron A, Borkowska J, Chmielewski D, Sadowski K, et al. Early diagnosis of tuberous sclerosis complex: a race against time. How to make the diagnosis before seizures? Orphanet J Rare Dis. 2018;13(1):25.","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"1072_CR36","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/ajmg.c.31651","volume":"178","author":"A Peron","year":"2018","unstructured":"Peron A, Au KS, Northrup H. Genetics, genomics, and genotype-phenotype correlations of TSC: insights for clinical practice. Am J Med Genet C Semin Med Genet. 2018;178(3):281\u201390.","journal-title":"Am J Med Genet C Semin Med Genet."},{"issue":"5","key":"1072_CR37","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.ejpn.2018.05.006","volume":"22","author":"P Curatolo","year":"2018","unstructured":"Curatolo P, Nabbout R, Lagae L, Aronica E, Ferreira JC, Feucht M, et al. Management of epilepsy associated with tuberous sclerosis complex: updated clinical recommendations. Eur J Paediatr Neurol. 2018;22(5):738\u201348.","journal-title":"Eur J Paediatr Neurol"},{"issue":"5","key":"1072_CR38","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.ejpn.2011.03.010","volume":"15","author":"S Jozwiak","year":"2011","unstructured":"Jozwiak S, Kotulska K, Domanska-Pakiela D, Lojszczyk B, Syczewska M, Chmielewski D, et al. Antiepileptic treatment before the onset of seizures reduces epilepsy severity and risk of mental retardation in infants with tuberous sclerosis complex. Eur J Paediatr Neurol. 2011;15(5):424\u201331.","journal-title":"Eur J Paediatr Neurol"},{"issue":"6","key":"1072_CR39","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1111\/dmcn.13352","volume":"59","author":"S Amin","year":"2017","unstructured":"Amin S, Lux A, Calder N, Laugharne M, Osborne J, O'Callaghan F. Causes of mortality in individuals with tuberous sclerosis complex. Dev Med Child Neurol. 2017;59(6):612\u20137.","journal-title":"Dev Med Child Neurol"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-019-1072-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-019-1072-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-019-1072-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T10:07:32Z","timestamp":1589882852000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-019-1072-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,30]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1072"],"URL":"https:\/\/doi.org\/10.1186\/s13023-019-1072-y","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,30]]},"assertion":[{"value":"4 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"S Auvin has served as a speaker and consultant for Advicenne Pharma, Eisai, GW Pharmaceuticals, Novartis Pharmaceuticals, Nutricia, UCB Pharma, Ultragenyx, Vitaflo, and Zogenix.JJ Bissler has received research grants (to his institution) from Novartis, has served as a consultant for and participated in advisory boards for Novartis, and has received travel honoraria from Novartis.V Cottin has served as a consultant and speaker for and received travel honoraria from Actelion Pharmaceuticals, Boehringer Ingelheim, and Roche Pharmaceuticals, has received research grants (to his institution) from Roche and Sanofi, served as a consultant for Bayer \/ MSD, Novartis, and Galapagos, and served as a committee member for Gilead Sciences, Promedior, and Celgene.A Fujimoto has nothing to disclose.GFL Hofbauer has received speaker\u2019s fees and consulting honoraria from Novartis.AC Jansen has received honoraria from Novartis and has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in, or financial conflict with, the subject matter of material discussed in the manuscript.S J\u00f3\u017awiak was partly financed by the European Community\u2019s Seventh Framework Programme (FP7\/2007\u20132013; EPISTOP, grant agreement no. 602391), the Polish Ministerial funds for science (years 2013\u20132019) for the implementation of international co-financed project and the grant EPIMARKER of the Polish National Center for Research and Development No STRATEGMED3\/306306\/4\/2016.L Kerecuk has served as a speaker for and received travel honoraria from Novartis, and as a consultant for Roche Pharmaceuticals.JC Kingswood has received research grants (to his institution) from Novartis and has served as a consultant for Novartis.R Moavero has participated in advisory boards for Novartis and has research that was partly funded by EPISTOP.R Torra has nothing to disclose.V Villanueva has participated in advisory boards and symposia for Eisai, UCB Pharma, BIAL, Esteve, Novartis, and GW Pharma.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"91"}}